KabrajiLab

PI: @skabrajiMD @RoswellPark We use #sysbio #microscopy #GEMM #patientTissues to map, track and attack #quiescent #cancer cells in #bcsm and other solid tumors

[KabrajiLab @KabrajiLab]

3 grants submitted this month to support our effort 🎯 quiescent cancer cells in #bcsm!

Great work Maia Homsi and Vittal Kurisetty! @AmericanCancer @theNCI @SKabrajiMD

[KabrajiLab @KabrajiLab]

Perfect place for #AACR24. On Wednesday come hear about our ongoing work dissecting residual disease in #HER2+ #bcsm @RoswellPark 6939 - Residual disease after HER2 inhibition is driven by a primary tumor subpopulation expressing an ERBB2-low associated transcriptional program

[KabrajiLab @KabrajiLab]

Bonne chance first NIH grant! @SKabrajiMD

[KabrajiLab @KabrajiLab]

We will be presenting an abstract @AACR #AACR24 ! Details of format to follow. See you in San Diego! @SKabrajiMD

[KabrajiLab @KabrajiLab]

Dedicated #CyCIF station? Oh yes!

⁦@RoswellPark⁩ ⁦@SKabrajiMD⁩ ⁦@HiTSatHarvard⁩ ⁦@JiaRenLin⁩ ⁦@SantagataLab⁩

[KabrajiLab @KabrajiLab]

New lab website: who dis?

@SKabrajiMD @RoswellPark

https://t.co/0dxJXlIFvv

[KabrajiLab @KabrajiLab]

@MaiaRaine

[KabrajiLab @KabrajiLab]

Introducing lab members Dr Vittal Kurisetty, HRI scientist (left), and Maia Homsi, research technologist (middle), running the first #CyCIF experiment in @KabrajiLab with @SKabrajiMD trying not to get in the way! @RoswellPark

[Sheheryar Kabraji @SKabrajiMD]

It’s the proliferation, s——

Spatial predictors of immunotherapy response in triple-negative breast cancer | Nature https://t.co/B17PsPDKVa

[KabrajiLab @KabrajiLab]

60 day Progress report:

✅ one foundation LOI submitted
✅ one federal grant submitted
✅ one scientist and one technician starting this week
✅ new collaborators
✅ new mentees
✅ fun!

@SKabrajiMD @RoswellPark @SusanGKomen

[KabrajiLab @KabrajiLab]

It was a great first day

[KabrajiLab @KabrajiLab]

New beginnings! @SKabrajiMD